Gastric Stromal Tumors in Children

Pediatric Blood and Cancer

Volumn 42, Issue 2, 2004, Pages 186-189

  Haider, Nadeem ^a,c   Kader, M ^a   Mc Dermott, M ^b   Devaney, D ^a   Corbally, M T ^a   Fitzgerald, R J ^a  

^a OUR LADY S CHILDREN S HOSPITAL   (Ireland)

^b CHILDREN S UNIVERSITY HOSPITAL   (Ireland)

^c NONE   (United Kingdom)

Author keywords

Childhood tumors; Gastrointestinal stromal tumors (GIST); Leiomyosarcoma; Soft tissue sarcoma

Indexed keywords

CANCER SURVIVAL; CASE REPORT; FEMALE; GASTROINTESTINAL STROMAL TUMOR; HISTOPATHOLOGY; HUMAN; MALE; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; SCHOOL CHILD; SOFT TISSUE SARCOMA; TREATMENT OUTCOME;

EID: 0842311647     PISSN: 00981532     EISSN: None     Source Type: Journal    
DOI: 10.1002/pbc.10387     Document Type: Review

References (18)

1. Jass JR, Sobin LH, editors. Histological typing of intestinal tumours. In: WHO international classification of tumours. 2nd edition. Berlin, New York: Springer-Verlag; 1990.
2. Lewin KJ, Appelman HD, editors. Tumours of esophagus and stomach. Atlas of tumour pathology. Washington, DC: AFIP; 1996.
3. Watanabe H, Jass JR, Sobin LH, editors. Histological typing of esophageal and gastric tumours. WHO international classification of tumours. 2nd edition. Berlin, New York: Springer-Verlag; 1990.
4. Trupiano JK, Stewart RE, Misick C, et al. Gastric stromal tumours. Am J Surg Pathol 2002;26:705-714.
5. Hirota S, Isozaki K, Moriyama Y, et al. Gain-of-function mutations of c-kit in human gastrointestinal stromal tumours. Science 1998;279:577-580.
6. Kindblom LG, Remotti HE, Aldenborg F, et al. Gastrointestinal pacemaker cell tumour (GIPACT): Gastrointestinal stromal tumours show phenotypic characteristics of the interstitial cells of Cajal. Am J Pathol 1998;152:1259-1269.
7. Sarlomo-Rikala M, Kovatich A, Barusevicius A, et al. CD 117: A sensitive marker for gastrointestinal stromal tumours that is more specific than CD34. Mod Pathol 1998;11:728-734.
8. Sircar K, Hewlett BR, Huizinga JD, et al. Interstitial cells of Cajal as precursors for gastrointestinal stromal tumours. Am J Surg Pathol 1999;23:377-389.
9. Miettinen M, Sarlimo-Rikala M, Lasota J. Gastrointestinal stromal tumours. Ann Chir Gynaecol 1998;87:278-281.
10. Evans HL. Smooth muscle tumours of the gastrointestinal tract. A study of 56 cases followed for a minimum of 10 years. Cancer 1985;56:2242-2250.
11. Salmela H. Smooth muscle tumours of the stomach. Acta Chir Scand 1968;134:384-391.
12. Appelman HD, Helwig EB. Cellular leiomyomas of the stomach in 49 patients. Arch Pathol Lab Med 1977;101:373-377.
13. Appelman H. Stromal tumours of the esophagus, stomach, and duodenum. In: Appelman HD, editor. Pathology of the esophagus, stomach, and duodenum. New York: Churchill Livingstone; 1984. pp 195-242.
14. Franquemont DW. Differentiation and risk assessment of gastrointestinal stromal tumours. Am J Clin Pathol 1995;103:41-47.
15. Roy M, Sommers SC. Metastatic potential of gastric leiomyosarcoma. Pathol Res Pract 1989;185:874-877.
16. Appelman HD, Helwig EB. Gastric epithelioid leiomyomas and leiomyosarcomas (leiomyoblastomas). Cancer 1976;38:708-728.
17. Joensuu H, Roberts PJ, Sarlomo-Rikala M, et al. Effect of the tyrosine kinase inhibitor STI 571 in a patient with a metastatic gastrointestinal stromal tumour. N Engl J Med 2001;344:1052-1056.
18. GIST workshop. Sponsored by the NIH office of rare diseases, The Armed Forces Institute of Pathology and The National Cancer Institute. Held in Bethesda, Maryland, April 2-3, 2001.